Favorable response to erlotinib in a lung adenocarcinoma with both epidermal growth factor receptor exon 19 deletion and K-ras G13D mutations

Research output: Contribution to journalArticle

16 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume28
Issue number7
DOIs
Publication statusPublished - Mar 1 2010

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this